HELP     Sign In
Search

Relevance to Autism

TAOK2 resides within the 16p11.2 microdeletion/microduplication region; deletions and duplications in this region are strongly associated with neurodevelopmental disorders, including ASD. A de novo loss-of-function (LoF) variant in the TAOK2 gene was identified in an ASD proband from a multiplex family in Yuen et al., 2017, while a second LoF variant in this gene was identified in another ASD proband in Lim et al., 2017. Taok2 heterozygous and knockout mice were found to display gene dosage-dependent impairments in cognition, anxiety, and social interaction, as well as dosage-dependent abnormalities in brain size and neural connectivity in multiple regions, deficits in cortical layering, dendrite and synapse formation, and reducted excitatory neurotransmission (Richter et al., 2018). Richter et al., 2018 also reported TAOK2 genetic variants identified by whole-genome and -exome sequencing of over 2600 families with ASD, including two de novo likely gene-disruptive variants [a missense variant (p.Ala135Pro) that was experimentally shown to display reduced kinase activity and alter dendrite growth and spine/synapse development, as well as a splice-site variant] in simplex families. Scharrenberg et al., 2022 showed that overexpression of TAOK2 with ASD-associated variants disrupted neuronal migration in an isoform-specific manner, neurons lacking Taok2 had unstable microtubules with reduced levels of acetylated tubulin and phosphorylated JNK1, mice lacking Taok2 developed gross cortical and cortex layering abnormalities, and acute Taok2 downregulation or Taok2 knockout delayed the migration of upper-layer cortical neurons in mice.

Molecular Function

This gene encodes a serine/threonine protein kinase that is involved in many different processes, including, cell signaling, microtubule organization and stability, and apoptosis.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder
ASD
Support
Autism spectrum disorder susceptibility gene TAOK2 affects basal dendrite formation in the neocortex.
Support
The autism susceptibility kinase, TAOK2, phosphorylates eEF2 and modulates translation
Support
TAOK2 is an ER-localized kinase that catalyzes the dynamic tethering of ER to microtubules
Support
Conserved Tao Kinase Activity Regulates Dendritic Arborization, Cytoskeletal Dynamics, and Sensory Function in Drosophila
ASD
Support
Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder.
ASD
Support
TAOK2 Kinase Mediates PSD95 Stability and Dendritic Spine Maturation through Septin7 Phosphorylation.
Recent Recommendation
TAOK2 rescues autism-linked developmental deficits in a 16p11.2 microdeletion mouse model
ASD
Recent Recommendation
Altered TAOK2 activity causes autism-related neurodevelopmental and cognitive abnormalities through RhoA signaling.
ASD
Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN1006R001 
 frameshift_variant 
 TGGGCCCCCCTGCTGCCGCGGTGCCC>T 
 p.Pro1022Ter 
 De novo 
  
 Multiplex 
 GEN1006R002 
 stop_gained 
 c.1162G>T 
 p.Glu388Ter 
 De novo 
  
 Simplex 
 GEN1006R003 
 missense_variant 
 c.403G>C 
 p.Ala135Pro 
 De novo 
  
 Simplex 
 GEN1006R004 
 splice_site_variant 
 c.563+12_563+15del 
  
 De novo 
  
 Simplex 
 GEN1006R005 
 frameshift_variant 
 c.2749del 
 p.Leu917TrpfsTer3 
 Familial 
 Paternal 
 Multiplex 
 GEN1006R006 
 frameshift_variant 
 c.1811_1865del 
 p.Thr604SerfsTer45 
 Unknown 
  
 Simplex 
 GEN1006R007 
 stop_gained 
 c.1864C>T 
 p.Gln622Ter 
 Unknown 
  
 Simplex 
 GEN1006R008 
 missense_variant 
 c.1004C>T 
 p.Ala335Val 
 Familial 
 Paternal 
  
 GEN1006R009 
 missense_variant 
 c.1466G>A 
 p.Arg489Gln 
 Familial 
 Paternal 
 Multiplex 
 GEN1006R010 
 missense_variant 
 c.2233-96C>T 
  
 Familial 
 Paternal 
  
 GEN1006R011 
 missense_variant 
 c.2233-66G>A 
  
 Familial 
 Paternal 
  
 GEN1006R012 
 missense_variant 
 c.2474G>A 
 p.Cys825Tyr 
 Familial 
 Paternal 
  
 GEN1006R013 
 missense_variant 
 c.2512C>A 
 p.Leu838Ile 
 Familial 
 Paternal 
 Simplex 
 GEN1006R014 
 missense_variant 
 c.2987G>A 
 p.Arg996Gln 
 Familial 
 Maternal 
  
 GEN1006R015 
 missense_variant 
 c.3001C>G 
 p.Leu1001Val 
 Familial 
 Maternal 
 Multiplex 
 GEN1006R016 
 missense_variant 
 c.3046G>A 
 p.Val1016Ile 
 Familial 
 Maternal 
 Multiplex 
 GEN1006R017 
 missense_variant 
 c.3337C>T 
 p.Arg1113Cys 
 Familial 
 Maternal 
 Multiplex 
 GEN1006R018 
 missense_variant 
 c.3355C>A 
 p.Pro1119Thr 
 Familial 
 Maternal 
 Multiplex 
 GEN1006R019 
 missense_variant 
 c.2342A>G 
 p.Glu781Gly 
 Familial 
 Maternal 
  
 GEN1006R020 
 missense_variant 
  
  
 Unknown 
  
  
 GEN1006R021 
 missense_variant 
  
  
 Familial 
 Paternal 
  
 GEN1006R022 
 missense_variant 
 c.2609G>A 
 p.Trp870Ter 
 Familial 
 Maternal 
  
 GEN1006R023 
 missense_variant 
  
  
 Familial 
 Maternal 
  
 GEN1006R024 
 missense_variant 
  
  
 Unknown 
 Not maternal 
  
 GEN1006R025 
 missense_variant 
  
  
 Familial 
 Maternal 
  
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
16
Deletion-Duplication
 150
  construct
16
Duplication
 7
 
16
Deletion
 1
 
16
Deletion
 1
 
16
Duplication
 16
 

Model Summary

C57BL6/J Taok2 HT and HM KO mice exhibit abnormal brain morphology, increased brain volume, reduced volume of somatosensory cortex, reduced cerebral cortex, abnormal morphology and size of the corpus callosum, increased ambulation, decreased anxiety, decreased social approach, decreased basal dendrite arborization in the PFC, abnormal spine morphology, decreased synapse number, decreased excitatory neurotransmission, and decreased RhoA activation (Richter M, et al, Mol. Psych., 2018).

References

Type
Title
Author, Year
Primary
Altered TAOK2 activity causes autism-related neurodevelopmental and cognitive abnormalities through RhoA signaling.
Additional
TAOK2 rescues autism-linked developmental deficits in a 16p11.2 microdeletion mouse model
Model Type: Genetic
Model Genotype: Homozygous
Mutation: Taok2 homozygous knockout mice were generated through Cre mediated deletion of lox P sites within the first and seventh introns of the Taok2 gene. C57BL/6Jtyrc-2Jmice carry a recessive point mutation in the tyrosinase gene resulting in a white coat color, allowing the distinction of targeted cells that confer a black coat color. .
Allele Type: knockout
Strain of Origin: C57BL/6NTac
Genetic Background: C57BL/6 * C57BL/6NTac * SJL
ES Cell Line:
Mutant ES Cell Line: PRX-B6N; C57BL/6J^tyrc-2J-derived blastocysts
Model Source: MGI:5554941
Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity: ambulatory activity1
Increased
 Open field test
 2-2.5 months
Brain size1
Decreased
 Magnetic resonance imaging (mri)
 2-2.5 months
Dendritic architecture: dendritic tree complexity1
Decreased
 Golgi-cox staining
 3 weeks
Cortical lamination1
Decreased
 Immunostaining
 2-2.5 months
Morphology and size of the corpus callosum1
Decreased
 Diffusion tensor imaging (dti)
 4 months
Anatomical projections and connectivity1
Increased
 In vivo local field potential (lfp) recordings
 P8-10
Dendritic architecture: dendritic tree complexity1
Decreased
 Golgi-cox staining
 3 weeks
Brain size1
Decreased
 Magnetic resonance imaging (mri)
 4 weeks
Dendritic architecture: spine morphology1
Abnormal
 Golgi-cox staining
 3 weeks
Dendritic architecture: dendritic length1
Decreased
 Golgi-cox staining
 3 weeks
Brain size1
Increased
 Magnetic resonance imaging (mri)
 2-2.5 months
Dendritic architecture: spine density1
Decreased
 Golgi-cox staining
 3 weeks
Cortical thickness1
Decreased
 Immunostaining
 2-2.5 months
Synapse density1
Decreased
 Electron microscopy
 3 weeks
Miniature post synaptic current frequency: excitatory1
Decreased
 Whole-cell patch clamp
 3-4 weeks
Local field potential1
Decreased
 In vivo local field potential (lfp) recordings
 P8-10
Intrinsic bursting events or spikes1
Increased
 In vivo local field potential (lfp) recordings
 P8-10
Social approach1
Decreased
 Three-chamber social approach test
 2-2.5 months
Size/growth1
Decreased
 Body weight measurement
 P7-10
Anxiety1
Decreased
 Elevated plus maze test
 2-2.5 months
Exploratory activity: habituation1
Decreased
 Open field test
 2-2.5 months
Anxiety1
Decreased
 Open field test
 2-2.5 months
Spatial working memory1
Decreased
 Y-maze test
 2-2.5 months
Cued or contextual fear conditioning: memory of context1
Decreased
 Fear conditioning test
 2-2.5 months
Spatial reference memory1
Increased
 Morris water maze test
 2-2.5 months
Object recognition memory1
Decreased
 Object-place recognition test
 2-2.5 months
Spatial working memory1
Increased
 Morris water maze test
 2-2.5 months
Cued or contextual fear conditioning: memory of context: long term recall1
Decreased
 Fear conditioning test
 2-2.5 months
Protein expression level evidence1
Increased
 Western blot
 2-2.5 months
Enzyme activity1
Decreased
 Western blot
 2-2.5 months
Targeted expression1
Decreased
 Western blot
 3 weeks
Thigmotaxis1
 No change
 Morris water maze test
 2-2.5 months
Cued or contextual fear conditioning: memory of context1
 No change
 Fear conditioning test
 2-2.5 months
Cued or contextual fear conditioning: memory of context: long term recall1
 No change
 Fear conditioning test
 2-2.5 months
Spatial learning1
 No change
 Morris water maze test
 2-2.5 months
Swim distance1
 No change
 Morris water maze test
 2-2.5 months
General locomotor activity: ambulatory activity1
 No change
 Three-chamber social approach test
 2-2.5 months
General locomotor activity: ambulatory activity1
 No change
 Object-place recognition test
 2-2.5 months
Swimming ability1
 No change
 Morris water maze test
 2-2.5 months
Dendritic architecture: dendritic tree complexity1
 No change
 Golgi-cox staining
 3 weeks
Dendritic architecture: spine density1
 No change
 Golgi-cox staining
 3 weeks
Morphology and size of the corpus callosum1
 No change
 Diffusion tensor imaging (dti)
 1 week, 1 month, 4 months, 13 months
Neocortex morphology1
 No change
 Immunostaining
 2-2.5 months
Local field potential1
 No change
 In vivo local field potential (lfp) recordings
 P8-10
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell patch clamp
 3-4 weeks
Miniature post synaptic current amplitude: inhibitory1
 No change
 Whole-cell patch clamp
 3-4 weeks
Miniature post synaptic current frequency: inhibitory1
 No change
 Whole-cell patch clamp
 3-4 weeks
 Not Reported: Circadian sleep/wake cycle, Communications, Immune response, Maternal behavior, Physiological parameters, Repetitive behavior, Seizure, Sensory

 

No Interactions Available
HELP
Copyright © 2017 MindSpec, Inc.